Abstract
Purpose:
To report the efficacy of intravitreal bevacizumab injection in treatment of macular edema in a case of optic disc vasculitis.
Design:
Retrospective case review.
Methods:
A patient diagnosed with macular edema due to optic disc vasculitis was treated with intravitreal bevacizumab injection.
Results:
One week after injection, fundus appearance dramatically improved and macular edema regressed. The patient was followed up for 1 year after injection and there was no recurrence of macular edema.
Conclusions:
This case suggests that intravitreal bevacizumab treatment might be effective in the management of macular edema in patients with optic disc vasculitis.
MeSH terms
-
Adult
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Behcet Syndrome / complications
-
Bevacizumab
-
Fluorescein Angiography
-
Humans
-
Injections
-
Macular Edema / diagnosis
-
Macular Edema / drug therapy*
-
Macular Edema / etiology
-
Male
-
Optic Disk / blood supply*
-
Retinal Vasculitis / complications*
-
Retrospective Studies
-
Tomography, Optical Coherence
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Visual Acuity
-
Vitreous Body
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Vascular Endothelial Growth Factor A
-
Bevacizumab